Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suping Li

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Carcinogenesis|May 3, 2019
Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical studyGuannan Wang, Chuang Chen, Priya Pai, et al.
ACS Applied Materials & Interfaces|January 14, 2016
An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic CancerTianjiao Ji, Suping Li, Yinlong Zhang, et al.
Frontiers in Oncology|May 1, 2025
Laparoscopic radical gastrectomy for gastric cancer: an anatomical approach to right mesogastrium excision and its clinical significanceGuofeng Pan, Zhixing Guo, Likui Huang, et al.
Molecular Pharmaceutics|March 27, 2025
Construction of Bispecific T-Cell Engager Radiotracer and Its Micro-PET Evaluation in Pancreatic CancerDan Wen, Qi Wang, Jin Ding, et al.
Frontiers in Pediatrics|October 24, 2022
Etiology and clinical characteristics of neonatal sepsis in different medical setting models: A retrospective multi-center studyYuanqiang Yu, Qingyi Dong, Suping Li, et al.
Nano Letters|June 11, 2019
Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated HypercoagulabilityShaoli Liu, Yinlong Zhang, Xiao Zhao, et al.
Nano Letters|March 2, 2021
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel ImpairmentBozhao Li, Tianjiao Chu, Jingyan Wei, et al.
Cell Reports Methods|August 3, 2023
Monitoring circulating platelet activity to predict cancer-associated thrombosisBozhao Li, Zefang Lu, Zhenlin Yang, et al.
Cancer Research|September 19, 2007
PC-1/PrLZ contributes to malignant progression in prostate cancerHui Zhang, Jian Wang, Bo Pang, et al.
Frontiers in Genetics|September 24, 2025
Mechanisms and recent advances in non-coding RNAs and RNA modifications in antiplatelet drug resistancePing Ni, Kejie Chen, Jing Xiang, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Carcinogenesis|May 3, 2019
Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical studyGuannan Wang, Chuang Chen, Priya Pai, et al.
ACS Applied Materials & Interfaces|January 14, 2016
An MMP-2 Responsive Liposome Integrating Antifibrosis and Chemotherapeutic Drugs for Enhanced Drug Perfusion and Efficacy in Pancreatic CancerTianjiao Ji, Suping Li, Yinlong Zhang, et al.
Frontiers in Oncology|May 1, 2025
Laparoscopic radical gastrectomy for gastric cancer: an anatomical approach to right mesogastrium excision and its clinical significanceGuofeng Pan, Zhixing Guo, Likui Huang, et al.
Molecular Pharmaceutics|March 27, 2025
Construction of Bispecific T-Cell Engager Radiotracer and Its Micro-PET Evaluation in Pancreatic CancerDan Wen, Qi Wang, Jin Ding, et al.
Frontiers in Pediatrics|October 24, 2022
Etiology and clinical characteristics of neonatal sepsis in different medical setting models: A retrospective multi-center studyYuanqiang Yu, Qingyi Dong, Suping Li, et al.
Nano Letters|June 11, 2019
Tumor-Specific Silencing of Tissue Factor Suppresses Metastasis and Prevents Cancer-Associated HypercoagulabilityShaoli Liu, Yinlong Zhang, Xiao Zhao, et al.
Nano Letters|March 2, 2021
Platelet-Membrane-Coated Nanoparticles Enable Vascular Disrupting Agent Combining Anti-Angiogenic Drug for Improved Tumor Vessel ImpairmentBozhao Li, Tianjiao Chu, Jingyan Wei, et al.
Cell Reports Methods|August 3, 2023
Monitoring circulating platelet activity to predict cancer-associated thrombosisBozhao Li, Zefang Lu, Zhenlin Yang, et al.
Cancer Research|September 19, 2007
PC-1/PrLZ contributes to malignant progression in prostate cancerHui Zhang, Jian Wang, Bo Pang, et al.
Frontiers in Genetics|September 24, 2025
Mechanisms and recent advances in non-coding RNAs and RNA modifications in antiplatelet drug resistancePing Ni, Kejie Chen, Jing Xiang, et al.
Pageof 20